Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib

BACKGROUND: Imatinib is a long-term, oral, targeted therapy for high-risk resected and advanced gastrointestinal stromal tumours (GIST). It is known that sarcopenia affects prognosis and treatment tolerance in patients with various solid cancers. We analysed lumbar skeletal muscle index changes in i...

Descripción completa

Detalles Bibliográficos
Autores principales: Moryoussef, Frédérick, Dhooge, Marion, Volet, Julien, Barbe, Coralie, Brezault, Catherine, Hoeffel, Christine, Coriat, Romain, Bouché, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670743/
https://www.ncbi.nlm.nih.gov/pubmed/26673372
http://dx.doi.org/10.1002/jcsm.12047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670743/
https://www.ncbi.nlm.nih.gov/pubmed/26673372
http://dx.doi.org/10.1002/jcsm.12047

Ejemplares similares